TXH11106: A Third-Generation MreB Inhibitor with Enhanced Activity against a Broad Range of Gram-Negative Bacterial Pathogens is a research paper published in Antibiotics (2022). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health grant
Grant: RO1 AI118874
NIAID NIH HHS
Grant: R01 AI118874
National Institutes of Health
Grant: 5R01AI118874-04
Development of New Antibiotics Against Multidrug-Resistant Staphylococcus aureus
Rutgers University Core Facilities Utilization Grant
FWCI
1.13
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals